Today: 8 June 2026
Microsoft stock slides after hours on AI disruption jitters — what’s next for MSFT

Microsoft stock slides after hours on AI disruption jitters — what’s next for MSFT

NEW YORK, Feb 3, 2026, 16:31 (ET) — Trading in after-hours

Microsoft shares fell 2.9% to $411.21 in after-hours trading Tuesday, following a drop during the main session. The stock started the day at $422.00 and fluctuated between $426.50 and $408.62, with roughly 59.9 million shares traded.

The decline followed a broader selloff in software and data-analytics stocks, sparked by new automation tools from Anthropic that reignited the “AI disruption” debate. “Sometimes the market just shoots first and asks questions later,” Mike Archibald of AGF Investments remarked. Jonathan McMullan at Schroders added that investors are “aggressively repricing” as the long-held valuation premium for predictability begins to erode. Reuters

This is crucial now as traders bet on one straightforward thesis: AI investment will boost the largest platforms—and quickly. Once new tools emerge that seem to handle tasks once billed by software, the narrative falters, and the stock ticker reacts accordingly.

Microsoft has faced increased scrutiny since its recent earnings report, which highlighted record AI investments alongside a slowdown in cloud-computing growth. This combination unsettled investors wary of short-term returns.

Piper Sandler stuck with its Overweight rating on Microsoft, signaling expectations that the stock will outperform. The firm held firm on a $600 price target, naming Microsoft a top pick despite cautioning that “seat-compression” might limit valuation multiples in the software sector. TipRanks

Seat compression refers to the risk that customers purchase fewer software “seats”—paid user licenses—as AI tools increase worker productivity. This presents a new challenge for a market accustomed to consistent subscription growth.

The danger is Tuesday’s selloff could linger: investors continue viewing AI as a margin risk for segments of the software stack, even as large firms pour cash into data centers to keep pace. In this environment, any relief rallies may prove fleeting.

The next big test comes with a packed earnings slate from megacap tech, as investors hunt for signs on cloud demand, AI spending, and competitive pressures. “We’re seeing a lot of software companies across the spectrum get hit,” noted Art Hogan of B. Riley Wealth. John Campbell at Allspring Global Investments added that expectations for AI “are really high.” All eyes will be on Alphabet on Wednesday and Amazon on Thursday for insights. Reuters

Stock Market Today

  • Altimeter Capital CEO Warns Traders on Potential Risks Ahead of SpaceX IPO
    June 8, 2026, 9:46 AM EDT. Brad Gerstner, CEO of Altimeter Capital, cautioned retail investors about challenges in upcoming big tech IPOs, including the anticipated SpaceX public offering. Gerstner highlighted that these initial public offerings (IPOs) could pose risks due to market volatility and heightened investor scrutiny. His warning signals the need for careful analysis as SpaceX, a major space exploration and satellite internet company, prepares to enter public markets. Investors are advised to stay alert amid these developments to navigate potential pitfalls.

Latest articles

Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
Why Freeport-McMoRan Inc (FCX) stock price is up nearly 6% today
Previous Story

Why Freeport-McMoRan Inc (FCX) stock price is up nearly 6% today

Cisco stock jumps after Evercore lifts target to $175 as earnings near
Next Story

Cisco stock jumps after Evercore lifts target to $175 as earnings near

Go toTop